How Does Continued Use of Green Light Therapy Impact Outcomes?

December 19, 2025 updated by: Efforia, Inc
Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This remotely administered decentralized trial is designed to meticulously investigate the effectiveness and potential benefits of green light therapy on body composition and overall well-being. As the wellness industry burgeons with claims of revolutionary treatments, the need for evidence-based research has never been more critical. Under the guidance of Ryan, the CEO of beem® Light Sauna, with an extensive background in the fitness and wellness industry, this study seeks to cut through the noise surrounding green light therapy. By leveraging the expansive network of beem®'s locations and their commitment to science-backed recovery modalities, this study aims to provide a robust evaluation of green light therapy's claims, focusing specifically on its impact on weight management and mood enhancement.

Participants in this study will engage in a series of green light therapy sessions, conducted entirely online to ensure convenience and broad accessibility. This innovative approach allows individuals from diverse geographical locations to partake in the study, enhancing the diversity of our participant pool and the generalizability of our findings. Throughout the study, participants will have their body composition meticulously analyzed, and their overall well-being assessed through scientifically validated measures, all from the comfort of their homes.

The primary objective of this investigation is to empower participants with tangible, personalized data concerning the effects of green light therapy on their health and wellness journey. By providing individualized feedback on changes in body composition and well-being, this study aims to illuminate the true efficacy of green light therapy. This endeavor not only seeks to validate or debunk existing claims but also to enrich the participant's understanding of their health, thereby enabling informed decisions regarding their wellness routines.

The significance of this study extends beyond the immediate benefits to the participants. By contributing to a pioneering exploration of green light therapy's potential in weight management and mood improvement, participants are at the forefront of a potentially transformative shift in health and wellness strategies. Although the study acknowledges limitations, including the necessity for subsequent comprehensive trials, the insights garnered here will pave the way for future health innovations. This trial stands as a beacon in the quest for truth, aiming to redefine approaches to weight management and wellness in an era increasingly focused on health consciousness.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • New York, New York, United States, 10003
        • Recruiting
        • Efforia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

  • Individuals with eye conditions
  • Individuals not active with Green Light Therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single arm where participants act as their own control
Single Arm observational where participants act as their own control

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².

The green light therapy provided in this study is set at 525 nm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Composition Measurement Form
Time Frame: Change from baseline (Day 1-3) in body composition at 4 weeks after the start of the intervention (Day 27-33).
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.
Change from baseline (Day 1-3) in body composition at 4 weeks after the start of the intervention (Day 27-33).
Quality of Life and Health Survey
Time Frame: Change from baseline (Day 1-3) in quality of life and health at 4 weeks after the start of the intervention (Day 27-33).
This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
Change from baseline (Day 1-3) in quality of life and health at 4 weeks after the start of the intervention (Day 27-33).
Body Image and Self-Perception Survey
Time Frame: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).
This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.
Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2025

Primary Completion (Estimated)

October 21, 2026

Study Completion (Estimated)

October 21, 2026

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

December 5, 2025

First Posted (Estimated)

December 15, 2025

Study Record Updates

Last Update Posted (Actual)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 47409

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Composition

Clinical Trials on EmeraldLED

Subscribe